• CB-5083 and p97 Inhibition: Deep Insights into Protein Homeo

  2026-04-30

  Explore the advanced mechanisms and unique research value of CB-5083, a potent p97 inhibitor, in protein homeostasis disruption and cancer apoptosis induction. This article offers a distinct, in-depth analysis informed by cutting-edge literature and practical assay guidance.

• Palonosetron Hydrochloride: Advances in Delayed CINV Managem

  2026-04-30

  This article examines recent advances in the management of chemotherapy- and radiotherapy-induced nausea and vomiting (CINV) with a focus on palonosetron hydrochloride. The reference study highlights the unique pharmacological properties and clinical efficacy of palonosetron, particularly for delayed CINV, and discusses its integration into clinical guidelines.

• Decitabine Enhances Anti–PD-1 Efficacy via CD8+ Progenitor T

  2026-04-29

  This study reveals that decitabine priming substantially improves anti–PD-1 immunotherapy by expanding and sustaining proliferative, cytolytic CD8+ progenitor exhausted T cells in tumor models. The mechanistic insights into epigenetic remodeling and JunD/AP-1 pathway activation inform future strategies for optimizing immunotherapy responsiveness.

• PR-619: Deubiquitylating Enzymes Inhibitor for Pathway Resea

  2026-04-29

  PR-619 stands out as a versatile, reversible deubiquitylating enzymes inhibitor for dissecting ubiquitination pathways in cancer and neurodegeneration models. Its broad DUB specificity and compatibility with autophagy and protein aggregation assays make it indispensable for advanced cell biology workflows.

• MLN4924: Precision NEDD8-Activating Enzyme Inhibition in Can

  2026-04-28

  Explore the scientific underpinnings and advanced assay decisions enabled by MLN4924, a potent NEDD8-activating enzyme inhibitor. This article uniquely bridges mechanistic insights with translational applications in cancer biology research.

• BIIE 0246: Precision Y2R Antagonism for Functional Circuit D

  2026-04-28

  Explore the advanced utility of BIIE 0246, a neuropeptide Y Y2 receptor antagonist, in dissecting functional neuronal circuits and modulating presynaptic inhibition. This cornerstone guide uniquely connects mechanistic insights to rigorous assay design, moving beyond translational overviews.

• Honokiol Triggers Paraptosis-Like Death in APL via mTOR & MA

  2026-04-27

  This study reveals that honokiol induces paraptosis-like cell death in acute promyelocytic leukemia (APL) cells through concurrent activation of mTOR and MAPK signaling pathways. The findings highlight a nonapoptotic, caspase-independent mechanism of cancer cell death, with implications for overcoming treatment resistance in APL.

• Fluconazole (SKU B2094): Optimizing Research on Fungal Resis

  2026-04-27

  This article provides a scenario-driven, evidence-based guide for researchers using Fluconazole (SKU B2094) in antifungal susceptibility, cytotoxicity, and Candida albicans infection models. It highlights practical challenges, quantitative benchmarks, and how APExBIO’s formulation enables reproducible results in antifungal drug resistance research.

• Discovery of ATG9A and PTOV1: New 14-3-3 Interactors in Canc

  2026-04-26

  This study uncovers ATG9A and PTOV1 as novel 14-3-3 binding proteins, elucidating their regulatory roles in autophagy and oncogenic signaling. Through integrated proteomic and biochemical approaches, the research provides mechanistic insight into basal autophagy and PTOV1 stability, informing new strategies for cancer biology.

• CD40 and STING Competition Drives B Cell Activation in ESCC

  2026-04-25

  This study reveals how CD40 and STING competitively bind TRAF2 to regulate IRF4-mediated B cell activation within tertiary lymphoid structures in esophageal squamous cell carcinoma (ESCC). These findings clarify key molecular mechanisms underlying adaptive antitumor immunity and suggest new avenues for biomarker and therapeutic development.

• Poria cocos Polysaccharides Mitigate ALD via NRF2/Ferroptosi

  2026-04-24

  This study uncovers how Poria cocos polysaccharides (PCP) ameliorate alcoholic liver disease (ALD) by modulating the NRF2 signaling pathway and suppressing ferroptosis. The findings highlight PCP's potential to regulate oxidative stress and inflammatory responses in ALD models, opening new avenues for targeted liver disease intervention.

• Ibrexafungerp vs. Caspofungin: Insights Against Resistant C.

  2026-04-24

  Wiederhold et al. investigate ibrexafungerp's in vitro and in vivo efficacy against fluconazole-resistant Candida auris, utilizing delayed therapy initiation in an experimental candidiasis model. The study benchmarks triterpenoid and lipopeptide antifungal drugs for activity against multidrug-resistant Candida, directly informing protocol optimization and resistance management strategies.

• Methionine γ-Lyase Essential for Biofilm in Synechococcus el

  2026-04-23

  This study demonstrates that a methionine γ-lyase homolog is indispensable for biofilm formation in the cyanobacterium Synechococcus elongatus. Through targeted genetic and protein-interaction experiments, the authors reveal that biofilm development requires specific enzymatic activity downstream of known biofilm gene induction, advancing our mechanistic understanding of cyanobacterial biofilm regulation.

• Affinity-Purified Goat Anti-Rabbit IgG (H+L): Workflow Maste

  2026-04-23

  Unlock next-generation sensitivity and reproducibility in immunoassays with the Affinity-Purified Goat Anti-Rabbit IgG (H+L), Horseradish Peroxidase Conjugated Secondary Antibody. This solution streamlines Western blot, ELISA, and IHC workflows, while minimizing troubleshooting cycles for complex translational research.

• Angiotensin III: Applied Protocols for Cardiovascular Resear

  2026-04-22

  Angiotensin III (human, mouse) unlocks high-fidelity RAAS signaling studies, serving as an optimal ligand for dissecting aldosterone secretion and pressor mechanisms. This guide delivers actionable protocols, troubleshooting strategies, and workflow enhancements to maximize reproducibility and interpretability in cardiovascular and neuroendocrine assays.

16521 records 1/1102 page Next 12345 下5页 Last page